Clinical, Not Real-World, Data is Still The Key To On- And Off-Label Reimbursement (Part 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
While payers have ever-more sophisticated datasets for observing drug use in the clinic, such information generally is “inconclusive” for reimbursement decisions, a managed care executive cautions.